PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | – | 3 | -25.0% | 0.00% | – |
Q2 2023 | $0 | -100.0% | 4 | -91.5% | 0.00% | -100.0% |
Q1 2023 | $2 | – | 47 | +487.5% | 0.00% | – |
Q4 2022 | $0 | – | 8 | +100.0% | 0.00% | – |
Q3 2022 | $0 | – | 4 | -33.3% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 6 | -87.8% | 0.00% | -100.0% |
Q1 2022 | $4,000 | 0.0% | 49 | -30.0% | 0.00% | -50.0% |
Q4 2021 | $4,000 | – | 70 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,799,916 | $121,768,000 | 8.62% |
Tamarack Advisers, LP | 625,000 | $27,044,000 | 8.22% |
NEXTHERA CAPITAL LP | 149,086 | $6,484,000 | 5.40% |
Spyglass Capital Management LLC | 379,609 | $16,509,000 | 5.22% |
Gagnon Advisors, LLC | 107,412 | $4,671,000 | 2.67% |
GAGNON SECURITIES LLC | 278,613 | $12,117,000 | 2.61% |
Asymmetry Capital Management, L.P. | 84,735 | $3,685,000 | 2.00% |
Rock Springs Capital Management LP | 1,250,000 | $54,363,000 | 1.97% |
Lisanti Capital Growth, LLC | 118,620 | $5,159,000 | 1.68% |
Elk Creek Partners, LLC | 500,069 | $21,748,000 | 1.62% |